Cargando…

Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study

BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 po...

Descripción completa

Detalles Bibliográficos
Autores principales: Arguni, Eggi, Supriyati, Endah, Hakim, Mohamad Saifudin, Daniwijaya, Edwin Widyanto, Makrufardi, Firdian, Rahayu, Ayu, Rovik, Anwar, Saraswati, Utari, Oktoviani, Farida Nur, Prastiwi, Nenes, Nuryastuti, Titik, Wibawa, Tri, Haryana, Sofia Mubarika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055379/
https://www.ncbi.nlm.nih.gov/pubmed/35531428
http://dx.doi.org/10.1016/j.amsu.2022.103676
Descripción
Sumario:BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 positive nasopharyngeal swabs in our COVID-19 referral laboratory in Yogyakarta, Indonesia, were tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR). Proportion of co-infection reported in percentage. RESULTS: Fifty-nine samples were positive for other viral respiratory pathogens among a total of 125 samples. Influenza A virus was detected in 32 samples, Influenza B in 16 samples, Human metapneumovirus in 1 sample, and adenovirus in 10 samples. We did not detect any co-infection with respiratory syncytial virus. Nine (7.2%) patients had co-infection with more than two viruses. CONCLUSION: Viral co-infection with SARS-CoV-2 is common. These results will provide a helpful reference for diagnosis and clinical treatment of patients with COVID-19.